Hemodialysis clearance and total body elimination of carbamazepine during chronic hemodialysis.
暂无分享,去创建一个
[1] L. Bertilsson,et al. Plasma kinetics of carbamazepine and its epoxide metabolite in man after single and multiple doses , 1975, European Journal of Clinical Pharmacology.
[2] L. Bertilsson,et al. Disposition of placentally transferred carbamazepine (Tegretol®) in the newborn , 1975, European Journal of Clinical Pharmacology.
[3] L. Bertilsson. Clinical Pharmacokinetics of Carbamazepine , 1978, Clinical pharmacokinetics.
[4] I. Leppik,et al. Salivary levels of anticonvulsants , 1977, Neurology.
[5] B. Höjer,et al. Kinetics of carbamazepine and its 10,11‐epoxide metabolite in children , 1976, Clinical pharmacology and therapeutics.
[6] A. Frigerio,et al. Formation of stable epoxides in the metabolism of tricyclic drugs. , 1976, Drug metabolism reviews.
[7] J. Spire,et al. Hemodialysis of phenytoin in a uremic patient , 1975, Clinical pharmacology and therapeutics.
[8] J. R. Green,et al. Pharmacokinetics of carbamazepine in normal man , 1975, Clinical pharmacology and therapeutics.
[9] F. Bochner,et al. Plasma protein binding of carbamazepine , 1975, Clinical pharmacology and therapeutics.
[10] P. Rasmussen,et al. FACIAL PAIN TREATED WITH CARBAMAZEPIN (TEGRETOL®) , 1970, Acta neurologica Scandinavica.